Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PDS-08 Pediatric Daily Synbiotic
- Development stage
- Unknown
- Lead developer
- Seed Health
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
PDS-08™ Pediatric Daily Synbiotic is a multi-strain synbiotic dietary supplement developed by Seed Health, Inc. for children and adolescents aged 3 to 17. It consists of a proprietary blend of 9 clinically studied probiotic strains (including *Lactobacillus rhamnosus* SD-GG-IT and *Lactobacillus acidophilus* SD-NCFM-US) and a dual-phase prebiotic comprising inulin and fructooligosaccharides (FOS). The formulation is designed to survive digestion and reach the lower small intestine and colon, where it promotes the enrichment of beneficial bacteria such as *Bifidobacterium*. PDS-08 is indicated to support digestive health, including the relief of intermittent constipation, as well as gut immune, dermatological, and respiratory health. While it has been evaluated in a double-blind, randomized, placebo-controlled clinical trial, it is marketed as a dietary supplement and is not FDA-approved to diagnose, treat, cure, or prevent any disease.
- Brand names
- PDS-08PDS08PDS 08PDS-08 Pediatric Daily SynbioticPDS08 Pediatric Daily SynbioticPDS 08 Pediatric Daily Synbiotic
- Other names
- Seed Pediatric Daily Synbiotic
Beyond the preview
Go deeper on PDS-08 Pediatric Daily Synbiotic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PDS-08 Pediatric Daily Synbiotic.